Post-traumatic Parotid Fistulae and Sialoceles. A Prospective Study of Conservative Management in 51 Cases
Overview
Authors
Affiliations
The management of parotid sialoceles and fistulae have been unsatisfactory in the past, and numerous methods of treatment with varying success and morbidity have been described. The present prospective study reports results of conservative therapy in 51 patients over a 3-year period. In 50 patients, the injury healed upon conservative management. During the early phase of the study, a limited conservative regimen through which the patients received nothing orally for 5 days only was used. During the latter part of the study, patients were administered nothing orally until complete healing of the injury. In terms of the time it took for healing of the injury, the differences of the two regimens (24 +/- 4 vs. 9.4 +/- 0.9 days) was highly significant (p less than 0.001). The response to conservative management depended on the severity of injury as demonstrated by sialography. Injury to minor intraparotid ducts (G1) healed in significantly less time compared with that to a major intraparotid duct (G2) or ductal injuries (p less than 0.001). There was no difference between the healing of G2 injury (10.3 +/- 1.8 days) and partial ductal transections (10.5 +/- 2.2 days) (p greater than 0.05). There was a significantly greater delay in healing with complete duct transections (21.5 +/- 3.7 days) compared with partial duct transections and G2 injuries (10.2 +/- 2.1 days) (p less than 0.01). There was no difference in the mean period for healing between salivary fistulae and sialoceles (p greater than 0.05). It is concluded that a new classification of parotid fistulae based on sialographic findings has prognostic and therapeutic value. Furthermore, the excellent results achieved with conservative therapy in this study suggest that it may be the initial treatment of choice for parotid fistulae.
Hosseinzadeh M, Rahimipour E, Mirzania N, Mohammadpour M Radiol Case Rep. 2024; 19(11):5268-5270.
PMID: 39280753 PMC: 11399788. DOI: 10.1016/j.radcr.2024.07.126.
Phalak J, Shukla D, Bhola N Cureus. 2024; 16(7):e65237.
PMID: 39184630 PMC: 11343336. DOI: 10.7759/cureus.65237.
Kulkarni V, Chowdhury S, Ghosh S, Rajkumar K J Maxillofac Oral Surg. 2024; 23(2):380-386.
PMID: 38601231 PMC: 11001829. DOI: 10.1007/s12663-021-01674-2.
Transdermal scopolamine for the treatment of recurrent parotid sialocele: a case report.
Lee C, Yi C, Bae Y, Lee J, Lee B, Kim J Arch Craniofac Surg. 2024; 25(1):44-47.
PMID: 38461828 PMC: 10924789. DOI: 10.7181/acfs.2023.00360.
Vielsmeier V, Hackenberg S, Schelzig H, Knapsis A HNO. 2022; 70(10):724-735.
PMID: 36066623 DOI: 10.1007/s00106-022-01214-5.